“University of Surrey researchers said the virus could “help revolutionise treatment” for the cancer and reduce the risk of it recurring.”
A recent study, carried out by the cancer immunotherapy research team at University of Surrey, involving 15 patients with bladder cancer were given the cancer-killing coxsackievirus (CVA21) through a catheter one week before surgery to remove their tumours.
Prof Hardev Pandha said, “The virus gets inside cancer cells and kills them by triggering an immune protein – and that leads to signalling of other immune cells to come and join the party,” he said.
To read more about this exciting study, click on a link below:
- Common cold virus could cure cancer, pioneering trial suggests – The Telegraph article (4th July, 2019) [wp-svg-icons icon=”new-tab” size=”13px” wrap=”i”]
Please Note: Telegraph account required to read full article. - Bladder cancer ‘attacked and killed by common cold virus’ – BBC Health article (5th July, 2019) [wp-svg-icons icon=”new-tab” size=”13px” wrap=”i”]
- Strain of common cold virus can help cure bladder cancer: Study – Business Standard article (5th July, 2019) [wp-svg-icons icon=”new-tab” size=”13px” wrap=”i”]
- Common cold could be new weapon used to destroy cancer cells – Silicon Republic article (5th July, 2019) [wp-svg-icons icon=”new-tab” size=”13px” wrap=”i”]